Add Formweb to your mobile device
Search results for:
nevirapine
nevirapine
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SUSPENSION, ORAL | 50 mg/5 mL | |||||||||||
| TABLET, ORAL | 200 mg |
Last updated: Nov. 30, 2021
- Black Box Warning: Hepatotoxicity; dermal reactions; patient monitoring
- Do Not Crush: Extended-release (b) Tablet
